We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Smith & Nephew Plc | LSE:SN. | London | Ordinary Share | GB0009223206 | ORD USD0.20 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.40 | -0.04% | 984.40 | 984.20 | 984.60 | 991.40 | 984.00 | 989.80 | 417,349 | 15:00:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Ortho,prosth,surg Appl,suply | 5.55B | 263M | 0.3011 | 32.71 | 8.6B |
TIDMSN.
RNS Number : 6133S
Smith & Nephew Plc
17 March 2021
SMITH & NEPHEW PLC
17 March 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Following the announcement on 9 March 2021, regarding the awards made under the Smith & Nephew Global Share Plan 2020 of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company"), those share awards vested on 16 March 2021.
1. FINAL VESTING ON 16 MARCH 2021 OF SUPPLEMENTARY AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020 FOR THE 2018 PERFORMANCE SHARE PROGRAMME AWARDS:
The awards were granted under the Global Share Plan 2020 on 8 March 2021. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
The following relates to all individuals included in the below notification:
Reason for the notification Initial notification Initial notification /Amendment ------------------------------------------------- Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Name Smith & Nephew plc ------------------------------------------------- LEI 213800ZTMDN8S67S1H61 ------------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted Description of the Smith & Nephew plc ordinary shares of financial instrument, USD 0.20 each type of instrument ------------------------------------------------- Identification code ISIN: GB0009223206 ------------------------------------------------- Nature of the transaction Final vesting on 16 March 2021 of Supplementary Awards granted under the Smith & Nephew Global Share Plan 2020 for the 2018 Performance Share Programme awards . ------------------------------------------------- Date of Transaction 2021 - 03 - 16 ------------------------------------------------- Place of Transaction London Stock Exchange (XLON) ------------------------------------------------- Total Ordinary Share Holding Total Ordinary as a % of Share Holding the Company's following ISC following Name Price Aggregated the transaction the transaction (Position) Status (GBP) Volume information * * 3,740 (of which 84,165.76313 Bradley Cannon 1,665 ordinary (President were sold shares (including Sports Medicine and 2,075 N/A Single 2,101.64550 & ENT) PDMR 14.0000 retained) Transaction in ADS') 0.00951% -------- -------- --------------- ------------- ------------------- ----------------- Phil Cowdy 1,781 (Chief Business (of which Development 841 were 45,298.19975 & Corporate sold and N/A Single ordinary Affairs Officer) PDMR 14.0000 940 retained) Transaction shares 0.00512% -------- -------- --------------- ------------- ------------------- ----------------- 2,848 (of which 106,816.00000 1,125 ordinary Elga Lohler were sold shares (including (Chief HR and 1,723 N/A Single 3,015.00000 Officer) PDMR 14.0000 retained) Transaction in ADS') 0.01207% -------- -------- --------------- ------------- ------------------- ----------------- 2,823 Catheryn (of which 81,517.23565 O'Rourke 963 were ordinary (Chief Legal sold and shares (including & Compliance 1,860 N/A Single 5,818.25734 Officer) PDMR 14.0000 retained) Transaction in ADS') 0.00921% -------- -------- --------------- ------------- ------------------- ----------------- 3,207 (of which Vasant Padmanabhan 1,089 (President were sold 64,620.00000 Research and 2,118 N/A Single ordinary & Development) PDMR 14.0000 retained) Transaction shares 0.00730% -------- -------- --------------- ------------- ------------------- ----------------- 1,255 (of which Susan Swabey 592 were 49,225.83952 (Company sold and N/A Single ordinary Secretary) PDMR 14.0000 663 retained) Transaction shares 0.00556% -------- -------- --------------- ------------- ------------------- -----------------
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFLEVTIDLIL
(END) Dow Jones Newswires
March 17, 2021 11:30 ET (15:30 GMT)
1 Year Smith & Nephew Chart |
1 Month Smith & Nephew Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions